Tonix Pharmaceuticals Secures Major Defense Contract for Antiviral Initiative
Monday, 1 July 2024, 12:36
Overview
Tonix Pharmaceuticals has secured a $34M contract from the Department of Defense (DoD) for their antiviral program.
Importance
This substantial funding will greatly enhance Tonix Pharmaceuticals' research capabilities and propel their antiviral initiatives.
Collaboration
The contract signifies a strategic partnership between Tonix Pharmaceuticals and the DoD.
Milestone
This achievement marks a significant milestone for the company's innovative healthcare solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.